Monday, November 13, 2017

Traykor

Description overdue on 01/15/2014

Related Articles:
  • Vitrum Antioxidant
  • The drug Octreotide
  • Doctors about Speman Forte
  • Reviews of Forte Chondroxide
Tweet

 Traykor  Hypolipidemics . Active ingredient - fenofibrate . The drug has antiplatelet and Traykor urikozuricheskim effects. Under the action of the medicament decreases total cholesterol by 20-25% and triglycerides   - 40-45%. Long-term therapy with fenofibrate leads to a decrease in extravascular cholesterol deposits. Active substance reduces aggregation of platelet cells, reduces the amount of fibrinogen It prevents excessive synthesize fatty acids It reduces the amount of "bad cholesterol", triglycerides and increases the rate of "good cholesterol". In individuals with diabetes is marked optional hypoglycemic effect . The drug comes in tablet form. Price Traykora - 800-1200 rubles.

Indications:

When elevated levels of cholesterol and triglycerides, with dyslipidemia is recommended subject to the special diet and concurrent medications Traykor. Instructions for use should appoint a drug in the secondary hyperlipoproteinemia   diabetes mellitus.

Contraindications:

Tablets are not prescribed for Traykor biliary cirrhosis , Hypersensitive to fenofibrate, the development of photosensitivity or phototoxicity during treatment with ketoprofen and fibrates history. The drug is contraindicated in pathology gallbladder , Breastfeeding, with galactosemia and fruktozemii. Animal experiments confirmed the absence of teratogenic effects   fenofibrate, but at high doses the drug was observed embryotoxicity . It is therefore not advisable to appoint Traykor 145 mg for pregnant women.


Side effect:

Observed gastrointestinal disorders such as vomiting   and   nausea . Rarely observed muscular weakness   (mainly in the legs), skin rashes type allergic reaction, edema and weight gain since fluid retention. All of the above symptoms disappear after the abolition of fenofibrate. Reviews Traykor to provide guidance to the emergence of cholestasis   during treatment. Patients describe all the signs of stagnation of bile. Rarely acute gallstone disease. The active ingredient can trigger the formation of stones in the lumen of the biliary tract, and in the gallbladder. In individuals with diabetes medication further reduces blood sugar, which may require dose adjustment of the main hypoglycemic medication.

Mode of application:

Traykor can be taken any time of day according to the scheme: 1 tablet a day. It is recommended that long-term treatment in compliance with a special diet for maximum effect.

Special instructions:

Analogs Traykora:   Protolipan, lipids, Lipantil, Nolipaks, Lipil, Panlipal, Elasterin. In the absence of effect on treatment with medication and compliance hypolipidemic diet   3-6 months is recommended to review the treatment regimen and to appoint an alternative therapy. Required control ALT and AST every 3 months of therapy. With their increasing fenofibrate canceled before stabilization "liver" enzymes. Buy Traykor can be a pharmacy by presenting the prescription form.

Drug Interactions:

There are bleeding   while the application anticoagulants . Miotoksicheskoe Traykora the effect is enhanced by receiving other fibrates and medicines, HMG-CoA reductase. Cyclosporine is a reversible reduction of functional renal and hepatic systems. Tablets are recommended to take an hour or 5 hours after eating fatty acid sequestrant.

No comments:

Post a Comment